Legal & General Group Plc

Position in CABA — Cabaletta Bio, Inc.

CIK 764068 London, X0

Position in CABA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$33,954

+$28,469 QoQ

Shares Held

10,918

+175.6% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#111

of 139 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. CABA ranks #210 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,870,015	$928,892,550
2	REGN	Regeneron Pharmaceuticals, Inc.	759,971	$473,872,316
3	ALNY	Alnylam Pharmaceuticals, Inc.	924,561	$278,320,596
4	RPRX	Royalty Pharma plc	3,800,504	$213,094,258
5	INCY	Incyte Corp	1,605,980	$182,053,892
6	ARGX	Argenx SE	177,164	$164,367,443
7	INSM	INSMED Inc	826,431	$88,114,072
8	RVMD	Revolution Medicines, Inc.	381,366	$71,422,223

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$33,954	10,918	+175.6%	Shares	Defined	2026-08-14
2025-03-31	$5,485	3,961	0.0%	Shares	Defined	2025-05-15
2024-12-31	$8,991	3,961	0.0%	Shares	Defined	2025-02-13
2024-09-30	$18,695	3,961	-85.2%	Shares	Defined	2025-02-28
2024-06-30	$199,864	26,720	+14.1%	Shares	Defined	2025-05-29
2024-03-31	$399,510	23,418	-8.6%	Shares	Defined	2025-05-29
2023-12-31	$581,368	25,611	-19.1%	Shares	Defined	2025-05-29
2023-09-30	$481,605	31,643	+944.0%	Shares	Defined	2023-11-14
2023-06-30	$39,130	3,031	+166.3%	Shares	Defined	2023-08-14
2021-03-31	$12,631	1,138	0.0%	Shares	Defined	2021-05-17
2020-12-31	$14,202	1,138	0.0%	Shares	Defined	2021-02-12
2020-09-30	$12,335	1,138	-30.0%	Shares	Defined	2020-11-13
2020-06-30	$18,113	1,626	+82.9%	Shares	Defined	2020-08-14
2020-03-31	$6,489	889	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.